(XLV) Health Care Sector Fund - Overview
ETF Category: Health | Exchange: NYSE (USA) | Market Cap: 37.188m USD | Total Return: 16.1% in 12m
Avg Turnover: 1.52B
Warnings
Extended 3d
Tailwinds
No distinct edge detected
The Health Care Select Sector SPDR Fund (XLV) utilizes a replication strategy to track the Health Care Select Sector Index, investing at least 95% of its assets in constituent securities. The portfolio covers a broad spectrum of sub-sectors, including pharmaceuticals, biotechnology, healthcare equipment, and managed care providers.
The funds non-diversified status allows for concentrated weightings in large-cap industry leaders, which often benefit from high barriers to entry due to patent protections and intensive R&D requirements. Since healthcare demand is largely inelastic, these companies frequently exhibit lower correlation to economic cycles compared to cyclical sectors.
Investors can evaluate the intrinsic value of these underlying holdings by exploring the analytical tools available at ValueRay.
Established in 1998, XLV serves as a primary benchmark for the U.S. healthcare equity market, capturing the performance of companies within the S&P 500 designated as healthcare entities.
- Medicare reimbursement rate updates pressure managed care organization margins
- GLP-1 weight loss drug demand drives pharmaceutical revenue growth
- Federal Trade Commission scrutiny of PBM practices impacts industry profitability
- High interest rates constrain biotech funding and life sciences R&D spending
As of June 08, 2026, the stock is trading at USD 153.01 with a total of 20,708,019 shares traded.
Over the past week, the price has changed by +2.37%,
over one month by +5.73%,
over three months by -0.40% and
over the past year by +16.09%.
Health Care Sector Fund has no consensus analysts rating.